Method for determination of inflammatory bowel disease
US8043832B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2007 |
| Grant date | Oct 25, 2011 |
| Priority date | — |
| Expiry date | Mar 30, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The instant invention provides a method for the differential diagnosis of inflammatory bowel disease which comprises,determining the relative ratio of G0 oligosaccharide represented by formula (I):to G2 oligosaccharide represented by formula (II):wherein G represents galactose, M represents mannose, GN represents N-acetylglucosamine and F represents fucose in serum IgG oligosaccharide fraction obtained from a patient with inflammatory bowel disease or a patient with suspicion of inflammatory bowel disease, anddiscriminating inflammatory bowel disease based on the obtained ratio.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.